The influence of TLR4 agonist lipopolysaccharides on hepatocellular carcinoma cells and the feasibility of its application in treating liver cancer

OBJECTIVE: This study was designed to explore the influence of Toll-like receptor 4 (TLR4) agonist lipopolysaccharides (LPS) on liver cancer cell and the feasibility to perform liver cancer adjuvant therapy. METHODS: Human liver cancer cell lines HepG2, H7402, and PLC/PRF/5 were taken as models, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Junsheng, Sun, Ranran, Shen, Shen, Yu, Zujiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551308/
https://www.ncbi.nlm.nih.gov/pubmed/26345468
http://dx.doi.org/10.2147/OTT.S86536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551308/
https://www.ncbi.nlm.nih.gov/pubmed/26345468
http://dx.doi.org/10.2147/OTT.S86536

Ejemplares similares